Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angioplasty, Balloon, Coronary | 7 | 2012 | 37 | 1.650 |
Why?
|
| Heart-Assist Devices | 5 | 2012 | 12 | 1.510 |
Why?
|
| Cardiac Catheterization | 6 | 2017 | 60 | 1.190 |
Why?
|
| Coronary Angiography | 10 | 2023 | 71 | 1.080 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 122 | 1.060 |
Why?
|
| Coronary Artery Disease | 4 | 2023 | 98 | 1.000 |
Why?
|
| Stents | 5 | 2010 | 76 | 0.930 |
Why?
|
| Coronary Stenosis | 4 | 2006 | 13 | 0.810 |
Why?
|
| Heart Failure | 3 | 2022 | 148 | 0.810 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2010 | 4 | 0.700 |
Why?
|
| Pulmonary Embolism | 4 | 2008 | 56 | 0.670 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 17 | 0.650 |
Why?
|
| Thrombectomy | 3 | 2008 | 28 | 0.620 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2023 | 20 | 0.590 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2023 | 14 | 0.590 |
Why?
|
| Heart Transplantation | 3 | 2010 | 25 | 0.580 |
Why?
|
| Aortic Valve | 4 | 2023 | 16 | 0.540 |
Why?
|
| Coronary Vessels | 3 | 2017 | 32 | 0.540 |
Why?
|
| Thrombosis | 2 | 2022 | 48 | 0.540 |
Why?
|
| Aneurysm, False | 2 | 2007 | 4 | 0.510 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 34 | 0.510 |
Why?
|
| Cardiology | 1 | 2016 | 42 | 0.500 |
Why?
|
| Humans | 39 | 2023 | 26260 | 0.500 |
Why?
|
| Treatment Outcome | 16 | 2023 | 3285 | 0.490 |
Why?
|
| Diastole | 4 | 2010 | 31 | 0.470 |
Why?
|
| Shock, Cardiogenic | 2 | 2012 | 7 | 0.440 |
Why?
|
| Whole Blood Coagulation Time | 2 | 2012 | 3 | 0.410 |
Why?
|
| Subclavian Artery | 2 | 2010 | 3 | 0.410 |
Why?
|
| Coronary Disease | 1 | 2012 | 64 | 0.380 |
Why?
|
| Drug-Eluting Stents | 2 | 2022 | 13 | 0.380 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 74 | 0.370 |
Why?
|
| Aorta | 1 | 2011 | 14 | 0.370 |
Why?
|
| Calcinosis | 2 | 2010 | 36 | 0.360 |
Why?
|
| Fibrinolytic Agents | 2 | 2011 | 55 | 0.360 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 25 | 0.360 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 2 | 2007 | 4 | 0.360 |
Why?
|
| Foreign-Body Migration | 2 | 2008 | 16 | 0.360 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 110 | 0.360 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 55 | 0.360 |
Why?
|
| Pericardium | 1 | 2010 | 18 | 0.350 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2009 | 12 | 0.350 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2010 | 3 | 0.340 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 7 | 0.340 |
Why?
|
| Vena Cava, Superior | 1 | 2010 | 2 | 0.340 |
Why?
|
| Angioplasty | 1 | 2010 | 6 | 0.340 |
Why?
|
| Artifacts | 2 | 2009 | 33 | 0.340 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2010 | 4 | 0.340 |
Why?
|
| Balloon Occlusion | 2 | 2007 | 8 | 0.340 |
Why?
|
| Hepatic Veins | 1 | 2010 | 10 | 0.340 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 5 | 0.340 |
Why?
|
| Coronary Artery Bypass | 2 | 2007 | 25 | 0.340 |
Why?
|
| Heart Diseases | 1 | 2010 | 62 | 0.330 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 23 | 0.330 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 40 | 0.300 |
Why?
|
| Coronary Aneurysm | 1 | 2007 | 1 | 0.290 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2007 | 7 | 0.290 |
Why?
|
| Vascular Surgical Procedures | 1 | 2007 | 21 | 0.290 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2023 | 4 | 0.280 |
Why?
|
| Mammary Arteries | 1 | 2007 | 8 | 0.280 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2023 | 18 | 0.280 |
Why?
|
| Coronary Thrombosis | 1 | 2007 | 7 | 0.280 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 47 | 0.280 |
Why?
|
| Male | 19 | 2021 | 14168 | 0.270 |
Why?
|
| Transducers, Pressure | 1 | 2006 | 4 | 0.260 |
Why?
|
| Ventricular Pressure | 1 | 2006 | 3 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2010 | 675 | 0.240 |
Why?
|
| Female | 14 | 2021 | 14520 | 0.240 |
Why?
|
| Postoperative Complications | 1 | 2010 | 825 | 0.230 |
Why?
|
| Heart Aneurysm | 1 | 2004 | 4 | 0.220 |
Why?
|
| Aged | 11 | 2021 | 8595 | 0.210 |
Why?
|
| Hypotension | 1 | 2022 | 28 | 0.210 |
Why?
|
| Adult | 9 | 2017 | 7516 | 0.190 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2012 | 7 | 0.190 |
Why?
|
| Conservative Treatment | 1 | 2021 | 15 | 0.180 |
Why?
|
| Middle Aged | 10 | 2011 | 8541 | 0.180 |
Why?
|
| Computed Tomography Angiography | 2 | 2017 | 24 | 0.180 |
Why?
|
| Hemodynamics | 2 | 2010 | 68 | 0.170 |
Why?
|
| Catheterization | 3 | 2010 | 44 | 0.170 |
Why?
|
| Health Resources | 1 | 2019 | 20 | 0.170 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 19 | 0.170 |
Why?
|
| Risk Assessment | 4 | 2021 | 592 | 0.160 |
Why?
|
| Network Meta-Analysis | 3 | 2023 | 30 | 0.150 |
Why?
|
| Constriction, Pathologic | 3 | 2010 | 30 | 0.150 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2007 | 26 | 0.150 |
Why?
|
| Retrospective Studies | 3 | 2023 | 3283 | 0.150 |
Why?
|
| Follow-Up Studies | 3 | 2007 | 1722 | 0.150 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2017 | 4 | 0.140 |
Why?
|
| Azygos Vein | 1 | 2017 | 3 | 0.140 |
Why?
|
| Incidental Findings | 1 | 2017 | 13 | 0.140 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 10 | 0.140 |
Why?
|
| Risk Factors | 5 | 2023 | 2221 | 0.140 |
Why?
|
| Phlebography | 3 | 2017 | 9 | 0.140 |
Why?
|
| Exercise Test | 1 | 2017 | 71 | 0.140 |
Why?
|
| Atrial Appendage | 1 | 2017 | 26 | 0.140 |
Why?
|
| Punctures | 2 | 2010 | 8 | 0.140 |
Why?
|
| Femoral Artery | 1 | 2016 | 3 | 0.130 |
Why?
|
| Radial Artery | 1 | 2016 | 7 | 0.130 |
Why?
|
| Hemorrhage | 2 | 2022 | 76 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 4594 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 2008 | 90 | 0.120 |
Why?
|
| Saphenous Vein | 2 | 2007 | 4 | 0.120 |
Why?
|
| Sinus of Valsalva | 2 | 2003 | 2 | 0.110 |
Why?
|
| Aortic Rupture | 2 | 2003 | 4 | 0.110 |
Why?
|
| Aortic Aneurysm | 2 | 2003 | 10 | 0.110 |
Why?
|
| Bayes Theorem | 2 | 2023 | 40 | 0.100 |
Why?
|
| Death | 2 | 2023 | 44 | 0.100 |
Why?
|
| Erectile Dysfunction | 1 | 2013 | 55 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 853 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 683 | 0.100 |
Why?
|
| Angioplasty, Balloon | 1 | 2011 | 12 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 20 | 0.090 |
Why?
|
| Echocardiography | 2 | 2008 | 92 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2011 | 37 | 0.090 |
Why?
|
| Peptides | 1 | 2011 | 97 | 0.090 |
Why?
|
| Hemostatic Techniques | 1 | 2010 | 7 | 0.080 |
Why?
|
| Prosthesis Design | 2 | 2009 | 492 | 0.080 |
Why?
|
| Septal Occluder Device | 1 | 2010 | 7 | 0.080 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2010 | 72 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 338 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 294 | 0.080 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2008 | 3 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2009 | 285 | 0.070 |
Why?
|
| Vena Cava Filters | 1 | 2008 | 8 | 0.070 |
Why?
|
| Gastrectomy | 1 | 2008 | 26 | 0.070 |
Why?
|
| Thoracotomy | 1 | 2007 | 25 | 0.070 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 9 | 0.070 |
Why?
|
| Angiography | 1 | 2007 | 29 | 0.070 |
Why?
|
| Chest Pain | 1 | 2007 | 16 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 1 | 2007 | 12 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2007 | 95 | 0.070 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2006 | 2 | 0.070 |
Why?
|
| Mitral Valve | 1 | 2006 | 6 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 15 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2006 | 45 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 60 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2006 | 193 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2019 | 130 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 20 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2004 | 56 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 16 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 17 | 0.050 |
Why?
|
| Child | 1 | 2007 | 1326 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2022 | 3 | 0.050 |
Why?
|
| Neprilysin | 1 | 2022 | 10 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 8 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 24 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2022 | 42 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2002 | 5 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 66 | 0.050 |
Why?
|
| Health Status | 1 | 2023 | 171 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 45 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 75 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 169 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2002 | 155 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 303 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2019 | 60 | 0.040 |
Why?
|
| Quality of Life | 1 | 2023 | 606 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2019 | 152 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 315 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 142 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 413 | 0.040 |
Why?
|
| Length of Stay | 1 | 2019 | 290 | 0.040 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2017 | 10 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 343 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1347 | 0.030 |
Why?
|
| Device Removal | 2 | 2008 | 89 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2043 | 0.030 |
Why?
|
| Contrast Media | 1 | 2008 | 69 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 468 | 0.020 |
Why?
|
| Computer Systems | 1 | 2006 | 7 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 95 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 211 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 473 | 0.010 |
Why?
|
| Prolapse | 1 | 2003 | 1 | 0.010 |
Why?
|
| Heart Atria | 1 | 2003 | 25 | 0.010 |
Why?
|
| Aortography | 1 | 2003 | 6 | 0.010 |
Why?
|
| Body Surface Area | 1 | 2002 | 2 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2002 | 8 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 2002 | 10 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 25 | 0.010 |
Why?
|